1. Home
  2. TIL vs VGZ Comparison

TIL vs VGZ Comparison

Compare TIL & VGZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIL
  • VGZ
  • Stock Information
  • Founded
  • TIL 2018
  • VGZ 1983
  • Country
  • TIL United States
  • VGZ United States
  • Employees
  • TIL N/A
  • VGZ N/A
  • Industry
  • TIL Biotechnology: Pharmaceutical Preparations
  • VGZ
  • Sector
  • TIL Health Care
  • VGZ
  • Exchange
  • TIL Nasdaq
  • VGZ Nasdaq
  • Market Cap
  • TIL 177.1M
  • VGZ 209.1M
  • IPO Year
  • TIL 2021
  • VGZ N/A
  • Fundamental
  • Price
  • TIL $12.74
  • VGZ $1.73
  • Analyst Decision
  • TIL Strong Buy
  • VGZ Strong Buy
  • Analyst Count
  • TIL 5
  • VGZ 1
  • Target Price
  • TIL $100.67
  • VGZ $3.00
  • AVG Volume (30 Days)
  • TIL 62.5K
  • VGZ 1.3M
  • Earning Date
  • TIL 11-13-2025
  • VGZ 11-12-2025
  • Dividend Yield
  • TIL N/A
  • VGZ N/A
  • EPS Growth
  • TIL N/A
  • VGZ N/A
  • EPS
  • TIL N/A
  • VGZ N/A
  • Revenue
  • TIL N/A
  • VGZ N/A
  • Revenue This Year
  • TIL N/A
  • VGZ N/A
  • Revenue Next Year
  • TIL N/A
  • VGZ N/A
  • P/E Ratio
  • TIL N/A
  • VGZ N/A
  • Revenue Growth
  • TIL N/A
  • VGZ N/A
  • 52 Week Low
  • TIL $10.80
  • VGZ $0.47
  • 52 Week High
  • TIL $42.79
  • VGZ $2.46
  • Technical
  • Relative Strength Index (RSI)
  • TIL 31.33
  • VGZ 47.66
  • Support Level
  • TIL $13.53
  • VGZ $1.67
  • Resistance Level
  • TIL $16.00
  • VGZ $1.89
  • Average True Range (ATR)
  • TIL 1.32
  • VGZ 0.11
  • MACD
  • TIL -0.22
  • VGZ 0.01
  • Stochastic Oscillator
  • TIL 7.95
  • VGZ 65.20

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

About VGZ Vista Gold Corp

Vista Gold Corp is a gold mining company. It is engaged in the evaluation, acquisition, exploration, and advancement of gold exploration and potential development projects. The company evaluate, acquire, explore and advance gold exploration and potential development projects for gold production or value adding strategic transactions. The Company has one reportable segment: Australia. The Australia segment conducts exploration, development, care and maintenance activities at Vista's asset, the Mt Todd gold project in Northern Territory, Australia.

Share on Social Networks: